World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
India Prepares EU Trade Complaint
Keywords:
Tags:
This article details the manner in which pharmaceutical companies like Sanofi, Novartis and other western pharma companies are using EU patent laws to have customs offices in the Netherlands and other European transit points to detain pharma shipments by Indian companies to developing countries. Cipla and Ind-Swift shipments are mentioned. India's pharma exports of generics and other medicines is $4.9 billion in 2009 according to Global Trade Information Services. Indian pharma companies are having to divert these shipments through Singapore and other transit poits to avoid this detaining of shipments and this costs more. India plans to file a complaint with the World Trade Organization according to India's commerce secretary, which one expert says it has agood chance of winning.
Pharmaceutical companies with Generics products are changing the marketplace.
07/26/2005
With growing demand for low cost affordable drugs the growth in sales of generics.
Grouped Articles
Indian Drug Maker Vies for Betapharm
Wall Street Journal 02/09/2006
Branded Drugs Settling More Generic Suits
Wall Street Journal 01/17/2006
Generics Eat Into Pfizer's Profit; Costs Offset Novartis Sales Gain
Wall Street Journal 01/20/2006
As Generics Pummel Its Drugs, Pfizer Faces Uncertain Future
Wall Street Journal 01/05/2006
Teva to Acquire Ivax, Another Maker of Generic Drugs
New York Times 07/26/2005
Wall Street Journal 07/26/2005
The shift in focus to growing markets for pharmaceuticals in developing countries.
05/29/2007
Western pharmaceutical companies are putting more emphasis on building sales in growing developing countries.
Grouped Articles
China Sentences Former Drug Regulator to Death
New York Times 05/29/2007
Glaxo's Garnier Is Taking the Heat
Wall Street Journal 07/09/2007
Prescription-Drug Sales Growth Is Expected to Slow
Wall Street Journal 11/01/2007
Glaxo Chief Charts New Growth Strategy
Wall Street Journal 06/10/2008
Outlook Is Cut for U.S. Drug Sales
Wall Street Journal 10/29/2008
Drug Firms Target Newly Rich Abroad
Wall Street Journal 11/05/2008
Meeting the cost concerns of governments and insurers. Efforts by pharmaceutical companies.
11/09/2006
Efforts by companies like GlaxoSMithKline to meet cost concerns of governments by linking pricing to the effectiveness of the drugs or treatments. Pharmaceutical pricing an issue with governments.
Grouped Articles
Wall Street Journal 11/09/2006
Glaxo Chief Charts New Growth Strategy
Wall Street Journal 06/10/2008
Pricey Drugs Put Squeeze on Doctors
Wall Street Journal 07/08/2008
Drug Makers Trim Prices for Health Overhaul
Wall Street Journal 06/22/2009
For Drug Makers, Concessions Have a Bright Side
Wall Street Journal 06/23/2009
New York Times 06/25/2009
Indian pharmaceutical companies and export markets.
02/09/2006
Grouped Articles
Indian Drugmakers Target Niche Markets
Wall Street Journal 04/19/2016
In Trade Deal, a Shift on Generics
Wall Street Journal 05/17/2007
Economist 11/08/2007
India's Drug Firms May Boost a Healthy Portfolio
Wall Street Journal 12/17/2007
Indian Companies Hit Their Stride
BusinessWeek 09/17/2007
BusinessWeek 09/04/2008
Patent protection for western pharmaceutical companies in emerging markets.
04/24/2007
Efforts by western companies to secure patent protection and the situation in different developing countries.
Grouped Articles
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
Abbott Looks to India for Shot in Arm
Wall Street Journal 08/26/2010
Economist 08/08/2015
Thai Showdown Spotlights Threat to Drug Patents
Wall Street Journal 04/24/2007
India Rejects Novartis Patent Claim
Wall Street Journal 07/07/2009
India Prepares EU Trade Complaint
Wall Street Journal 08/06/2009
Indian pharmaceutical companies and the growing demand in India.
02/09/2006
The rapidly growing Indian pharmaceutical companies. The Indian market $8 billion today will grow to $30 billion in the next 10 years as more people get access to better healthcare. Sales in the Middle East, Africa and Latin America, and outsourcing manufacture for western companies are additional sources of growth for these companies.
Grouped Articles
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
India Administers Price-Cap Dose to Drug Companies
Wall Street Journal 09/22/2014
Indian Drug Maker Vies for Betapharm
Wall Street Journal 02/09/2006
Economist 11/08/2007
India's Drug Firms May Boost a Healthy Portfolio
Wall Street Journal 12/17/2007
Indian Companies Hit Their Stride
BusinessWeek 09/17/2007
Pharmaceutical company pricing in the U.S. and Europe
11/09/2007
The pricing of pharmaceutical products and healthcare services in the U.S. and Europe.
Grouped Articles
The Soaring Cost of a Simple Breath
New York Times 10/12/2013
Glaxo Sues Abbott Labs Over AIDS Drug Pricing
Wall Street Journal 11/09/2007
India Prepares EU Trade Complaint
Wall Street Journal 08/06/2009
Democrats Say No to Cost Cap for Drug Makers
New York Times 08/07/2009
Economist 08/27/2009
Large Price Jumps Reported for Small but Vital Drugs
New York Times 01/11/2010
Indian pharmaceutical companies and patent challenges.
07/07/2009
Grouped Articles
India Orders Bayer to License Patented Cancer Drug
New York Times 03/12/2012
India Rejects Novartis Patent Claim
Wall Street Journal 07/07/2009
India Prepares EU Trade Complaint
Wall Street Journal 08/06/2009
India-E.U. trade pact could boost AIDS treatment costs, health workers say - The Washington Post
Washington Post 02/11/2012
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03/06/2012
AARP Study Says Price of Popular Drugs Rose 26%
New York Times 03/06/2012
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us
